Keros Therapeutics, Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 10.00M-0.01M18.00M-0.00M0.15M3.55M
Gross Profit 10.00M-0.01M18.00M-0.00M0.15M3.55M
Operating items
Research & Development 17.38M33.86M55.14M87.27M135.26M173.63M
Selling, General & Administrative 3.18M12.80M21.33M27.52M34.83M40.75M
Other Operating Expenses -2.56M-1.49M
Operating Expenses 20.56M46.66M76.47M114.79M170.09M214.38M
Operating Income -10.56M-46.66M-56.37M-114.79M-169.94M-210.83M
EBIT -10.56M-46.66M-56.37M-114.79M-169.94M-210.83M
Non-operating items
Interest & Investment Income -0.01M-0.01M
Other Non Operating Income 0.24M0.16M-0.38M-0.61M-0.21M-0.95M
Non Operating Income -1.77M1.12M-0.38M10.11M16.95M23.78M
Net income details
EBT -12.34M-45.53M-56.73M-104.68M-152.99M-187.05M
Tax Provisions -0.17M2.01M0.30M
Profit After Tax -12.34M-45.36M-58.74M-104.68M-152.99M-187.35M
Income from Continuing Operations -12.34M-45.36M-58.74M-104.68M-152.99M-187.35M
Consolidated Net Income -12.34M-45.36M-58.74M-104.68M-152.99M-187.35M
Income towards Parent Company -12.34M-45.36M-58.74M-104.68M-152.99M-187.35M
Net Income towards Common Stockholders -14.14M-45.36M-58.74M-104.68M-152.99M-187.35M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 18.19M20.19M23.40M27.54M29.96M40.51M
Shares Outstanding (Diluted Average) 15.51M23.33M25.24M29.45M37.44M
EBITDA -10.56M-46.66M-56.37M-114.79M-169.94M-210.83M
Tax Rate 0.38%